Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000096313-99-000007
Filing Date
1999-01-13
Accepted
1999-01-13 00:00:00
Documents
18
Period of Report
1998-09-30

Document Format Files

Seq Description Document Type Size
1 10-K 327302
2 EXHIBIT 3.8 EX-3.(I) 33743
3 EXHIBIT 3.9 EX-3.(I) 17855
4 EXHIBIT 3.10 EX-3.(I) 11357
5 EXHIBIT 3.11 EX-3.(I) 21747
6 EXHIBIT 3.12 EX-3.(I) 17489
7 EXHIBIT 3.13 EX-3.(I) 38652
8 EXHIBIT 4.7 EX-4 3190
9 EXHIBIT 4.8 EX-4 3193
10 EXHIBIT 4.9 EX-4 3204
11 EXHIBIT 4.10 EX-4 3205
12 CONTRACT WITH ML INDUSTRIES EX-10 18281
13 CONTRACT WITH MEDICAL FOODS, INC. EX-10 48756
14 CONTRACT WITH HARROGATE MARKETING LLC EX-10 25001
15 ROCKWOOD PURCHASE AGREEMENT, AS AMENDED EX-10 34480
16 CONSENT OF TANNER+CO. EX-23 584
17 CONSENT OF ARTHUR ANDERSEN LLP EX-23 395
18 EX-27 2224
  Complete submission text file 0000096313-99-000007.txt   613764
Mailing Address 2401 SOUTH FOOTHILL DRIVE SALT LAKE CITY UT 84109-1405
Business Address 2401 SOUTH FOOTHILL DRIVE SALT LAKE CITY UT 84109-1405 8014663441
BIOMUNE SYSTEMS INC (Filer) CIK: 0000714634 (see all company filings)

EIN.: 870380088 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-11472 | Film No.: 99505679
SIC: 2835 In Vitro & In Vivo Diagnostic Substances